Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
The Journal of Emergency Medicine|July 17, 2003
Delayed recovery associated with persistent serum concentrations after clozapine overdoseLyle Thomas, P Timothy PollakClinical Pharmacology and Therapeutics|April 3, 2004
Use of population modeling to define rational monitoring of amiodarone hepatic effectsP Timothy Pollak, Steven L ShaferJournal of Clinical Pharmacology|January 30, 2004
Teaching application of clinical pharmacology skills using unusual observations from clozapine overdosesP Timothy Pollak, Steven L ShaferCurrent Vascular Pharmacology|August 5, 2008
Amiodarone hepatotoxicityMohamed Babatin, Samuel S Lee, P Timothy PollakThe Canadian Journal of Cardiology|February 4, 2018
Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel SyndromeP Timothy Pollak, Gavin R Sun, Richard B KimPharmacological Research|July 27, 2010
Influence of peroxisome proliferator-activated receptor-alpha (PPARα) activity on adverse effects associated with amiodarone exposure in miceMatthew C Ernst, Christopher J Sinal, P Timothy PollakCJC Open|March 12, 2020
Treatment Decisions in Geriatric Cardiac Lymphoma Facilitated by Serial Cardiac Magnetic Resonance Imaging and Positron Emission TomographyP Timothy Pollak, Gurbir Brar, Krishna Poinen, et al.CJC Open|August 29, 2022
Tolerance of High-Dose Oral Amiodarone for Cardioversion of Atrial FlutterVincent K Le, Katherine M Kavanagh, Satish R Raj, et al.The Journal of Pharmacology and Experimental Therapeutics|July 22, 2004
Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activationTanya C McCarthy, P Timothy Pollak, Elyisha A Hanniman, et al.The Canadian Journal of Cardiology|March 8, 2006
The use of amiodarone for in-hospital cardiac arrest at two tertiary care centresP Timothy Pollak, Vinnie Wee, Ahmed Al-Hazmi, et al.Pageof 2